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International Research Ethics Education
Nearly 20 years ago, a series of trials evaluating short-
course zidovudine for the prevention of mother-to-
child transmission of human immunodeficiency virus
(HIV) provoked global controversy when the sponsors
were accused of ethical double standards—conducting
research on vulnerable developing country popula-
tions that would not be permitted in high-income
countries.1 Following this controversy, and responding
tounderrepresentationofdevelopingcountries in these
debates, the Fogarty International Center at the Na-
tional Institutes of Health (NIH) launched a grants pro-
gram to supportmasters-level, socioculturally relevant
training in research ethics in low- and middle-income
countries (LMICs).
Since the program began, the volume of research
inLMICsandthe fundsdevoted toglobalhealthhaveex-
panded substantially.2,3 Themajority of the research is
still sponsored by institutions based in high-income
countries, including pharmaceutical companies, gov-
ernmental agencies like NIH, and private foundations.
Someofthe increase inLMIC-basedresearchresults from
greater funding for diseases that affect people in these
countries; some is a result of private companies seek-
ing lower costs andpatients naive to treatment.2,4New
challengeshaveemerged,asLMICs increasinglymustad-
dress the dual burden of communicable and noncom-
municablediseases.Newtechnologies, includingwide-
spreadaccess tomobilephonesand thedecreasingcost
of genomic analysis, have expanded the scope of re-
search. Ethical controversies continue to arise, tarnish-
ing the reputationofglobalhealth researchand, in some
countries, halting research altogether.
In thefaceof thesechanges,grantees,programstaff,
and outside experts conducted a collaborative self-
assessment of the Fogarty International Center pro-
gram 12 years after its inception. Fourteen articles pre-
sent this extensive evaluation.5,6 The authors examine
thestateof researchethics inLMICs, summarize the les-
sons learned, identify futureneeds,andattempt tochart
a way forward to address them.
Despite significant progress, the mission of build-
ingresearchethicscapacity inLMICs isnot finished.How-
ever, the landscape of research and research ethics is
substantially different than in 2000. New approaches
are needed to build onwhat has been achieved and re-
spond to new challenges.
The State of Research Ethics in LMICs
From 2000 to 2010, with the support of other NIH
institutes and US government agencies, 20 training
programs graduated approximately 600 masters-level
trainees from 74 institutions in LMICs.7 The largest
numbers were from programs focused on single coun-
tries, including 76 from South Africa, 72 fromNigeria, 71
from India, and 41 from Egypt. The largest proportion
of awards (18/48, or 37.5%) and 40% of program fund-
ing focused on sub-Saharan Africa, which was thought
to have the least research ethics capacity in 2000.
Among the 60 grants funded through 2011, 26 awards
(43%) were awarded directly to LMIC institutions.
Some additional sources of support for research
ethics activities in LMICs are now available. These in-
clude the Society and Ethics program of the Wellcome
Trust, the ethics and regulatory projects of the Euro-
pean and Developing Countries Clinical Trials Partner-
ship, and the Human Heredity and Health in Africa
Ethical, Legal, and Societal Issues Research Program of
NIH (H3Africa ELSI). However, support for founda-
tional activities in research ethics (ie, education and re-
view)andforcareerdevelopmentofbioethicists inLMICs
remains limited.
During the last decade, the scope of ethical con-
cerns about health research in LMICs has expanded
and the discussion has become more sophisticated.
The research community and wider public continue to
express concerns about informed consent, standards
of care, potential exploitation, and the imposition of
Western views and regulatory systems on other coun-
tries. Much discussion has focused on the care that
research participants should receive during and after
trials and how communities that host research will
benefit. As multinational research has increased, fur-
ther pressing issues have emerged, including the
involvement of LMIC stakeholders in setting research
priorities, public-private collaborations, and the own-
ership of data and tissues. Concerns about the mis-
treatment of research participants has fueled regula-
tory changes and halted research in countries from
Costa Rica to India.
Future Vision and Strategies
In essence, the vision for research ethics education
shouldremainthesame:LMIC institutionsshouldbesup-
ported to develop and maintain expertise in research
ethics as a foundation for strong and equal collabora-
tion inglobalhealth research. Strategic changesarenow
required to reach the next level in realizing this vision.
First, more in-depth ethics expertise is needed in
LMICs for ethical review of research. As trainees have
graduated andmoved into leadership positions, as the
number of trainees in research-rich locations has in-
creased,andastheresearch infrastructure inmanycoun-
trieshasdeveloped, thesimplebuildingofawarenesshas
become less important. Inaddition, shortonlinecourses
in research ethics now reach many researchers. How-
ever, there are still insufficient individuals with exper-
tise in ethics to populate the research ethics commit-
teesof LMICs.Moreover, theamountofhealth research
conducted in LMICs continues to increase, leading to
evengreaterneed forexpert ethics review.An ideal goal
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is to have 1 committee member with in-depth ethics training serv-
ing on each high-volume-workload research ethics committee.
Achieving this goal will require continued support for masters-
level training and investment in building LMIC institutional capac-
ity to train individuals at this level.
Second, the challenging ethics of international research in HIV/
AIDS, genetics, mental health, addiction, health systems, andmany
more fields demand increased LMIC leadership. Even though indi-
viduals from LMICs contributed to discussions of research ethics
more than 15 years ago, the dialogue, conceptual analysis, and
development of international guidance remains dominated by
those from high-income countries. To inform decision making on
the issues most important to them, LMICs need the capacity to
engage in empirical and conceptual research in ethics. Achieving
this goal will require support for LMIC academic expertise in
research ethics, ie, PhD and postdoctoral training, as well as career
paths for research ethicists.
Third, many Fogarty International Center trainees face limited
institutional commitment, financial support, and professional rec-
ognition for teaching research ethics or participating in the ethical
reviewof research.Themomentumofexpertisegained,andtheser-
vices theyperform,willdissipate if traineesarenotsupported in their
countries. Research ethics in LMICs needs a business plan that can
ensure sustainability. Novel fundingmechanisms should be identi-
fied so that the sponsors and institutions that support health re-
searchwill support the ethical oversight this research requires. For
example, thismight entail charging fees for ethics reviewandallow-
ing grantees to cover the costs of review as overhead.
Fourth, new health research regulations and guidelines regu-
larly emerge from LMICs and international organizations. How-
ever, most health research enterprises are far from achieving effi-
cient and transparent systems that demonstrably protect research
participants. Researchethics shouldnotbe thoughtof as a commit-
tee, but as a set of values underlying health research, alongside the
responsible conduct of research and clinical ethics. The principles
of research ethics should be an integral and continuous compo-
nent of research training and practice for all involved in the re-
search enterprise. Everyone involved in research, from researchers
and students, to researchethics committee administrators, institu-
tionalofficials,andregulatorystakeholders,shouldreceivesomerole-
specific ethics training. Further context-specific resources that are
culturally appropriate and reflect LMIC issues should be developed
for theseeducationalneeds. In-personeducationcannowbesupple-
mented by the wide range of distance learning methods that have
been developed and tested in LMIC settings.
Conclusions
The work of the Fogarty grantees has generated models for effec-
tive international research ethics education. With partners around
the world, the grantees have transformed the research ethics land-
scape. However, the world of health research has also evolved.
Highly publicized problems with research in LMICs, from Guate-
mala to India, underscore the critical value of effective national sys-
tems to ensure that all studies meet international standards. Simi-
larly, discussions of how to test new drugs and vaccines for
diseases like Ebola illustrate the ongoing ethical challenges of con-
ducting research on humans. Unless the research community
responds to the ongoing and emerging needs in ethics, it risks fur-
ther scandals, the halting or delaying of valuable research, and
unethical research practices.
The vision of Fogarty International Center for the next decade
of researchethicseducation isencapsulated in the4proposedgoals:
(1) ensure sufficient expertise in ethics review by having someone
with long-termtrainingoneveryhigh-workloadresearchethicscom-
mittee, (2) develop LMIC capacity to conduct original research on
critical ethical issuesby supportingdoctoral andpostdoctoral train-
ing and career paths for research ethicists, (3)make research train-
ing and review at LMIC institutions sustainable by identifying addi-
tional fundingmechanisms andmodels, and (4) make institutional
research systems more ethical and efficient through context-
specific training integrated intoall levelsof scientific training.Achiev-
ing these goals will require coordinating the Fogarty International
Center’s effortswith those of others sponsors andwill require con-
tinuedsupport fromtheLMICs.AsLMICsbecomeindependentspon-
sors of research, they need to simultaneously support building re-
search ethics systems. Dialogue about our respective visions and
coordinated action in achieving them are essential to ensure a fu-
ture of ethical global health research.
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